BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26314580)

  • 1. Screening anthelmintic resistance to triclabendazole in Fasciola hepatica isolated from sheep by means of an egg hatch assay.
    Robles-Pérez D; Martínez-Pérez JM; Rojo-Vázquez FA; Martínez-Valladares M
    BMC Vet Res; 2015 Aug; 11():226. PubMed ID: 26314580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an egg hatch assay for the detection of anthelmintic resistance to albendazole in Fasciola hepatica isolated from sheep.
    Robles-Pérez D; Martínez-Pérez JM; Rojo-Vázquez FA; Martínez-Valladares M
    Vet Parasitol; 2014 Jun; 203(1-2):217-21. PubMed ID: 24576602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: proof of concept.
    Fairweather I; McShane DD; Shaw L; Ellison SE; O'Hagan NT; York EA; Trudgett A; Brennan GP
    Vet Parasitol; 2012 Feb; 183(3-4):249-59. PubMed ID: 21821359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
    Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
    Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep.
    Flanagan A; Edgar HW; Gordon A; Hanna RE; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Mar; 176(2-3):170-6. PubMed ID: 21112153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.
    Novobilský A; Amaya Solis N; Skarin M; Höglund J
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):141-147. PubMed ID: 27380550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of closantel ovicidal activity in Fasciola hepatica eggs.
    Solana MV; Mera y Sierra R; Scarcella S; Neira G; Solana HD
    Exp Parasitol; 2016 Jan; 160():49-53. PubMed ID: 26551411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a field isolate of Fasciola hepatica resistant to albendazole and susceptible to triclabendazole.
    Sanabria R; Ceballos L; Moreno L; Romero J; Lanusse C; Alvarez L
    Vet Parasitol; 2013 Mar; 193(1-3):105-10. PubMed ID: 23273779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
    Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
    Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triclabendazole resistance in Fasciola hepatica: First report in sheep from the Santa Cruz province, Argentinian Patagonia.
    Larroza M; Aguilar M; Soler P; Mora J; Roa M; Cabrera R; Martinez Stanziola JP; Ceballos L; Alvarez LI
    Vet Parasitol Reg Stud Reports; 2023 Oct; 45():100927. PubMed ID: 37783530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia.
    Elliott T; Muller A; Brockwell Y; Murphy N; Grillo V; Toet HM; Anderson G; Sangster N; Spithill TW
    Vet Parasitol; 2014 Feb; 200(1-2):90-6. PubMed ID: 24360656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
    Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single amino acid substitution in isozyme GST mu in Triclabendazole resistant Fasciola hepatica (Sligo strain) can substantially influence the manifestation of anthelmintic resistance.
    Fernández V; Estein S; Ortiz P; Luchessi P; Solana V; Solana H
    Exp Parasitol; 2015 Dec; 159():274-9. PubMed ID: 26542261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An experimental study on triclabendazole resistance of Fasciola hepatica in sheep.
    Gaasenbeek CP; Moll L; Cornelissen JB; Vellema P; Borgsteede FH
    Vet Parasitol; 2001 Feb; 95(1):37-43. PubMed ID: 11163696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep.
    Novobilský A; Averpil HB; Höglund J
    Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.